Bioceltix announces success in clinical trial of equine arthritis product. Company one step closer to registration and commercialization of breakthrough drug

A veterinary biotechnology company listed on the Warsaw Stock Exchange (GPW) has published the full results of a clinical trial of a product for equine arthritis. They confirm the efficacy and safety of the pioneering technology using mesenchymal stem cells. The results indicate that the therapeutic effect of a single dose of BCX-EM was achieved […]